{"id":"W4286561096","doi":"10.1038/s41416-022-01903-6","title":"Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"AstraZeneca","keywords":"Selumetinib; Gemcitabine; Medicine; Chemotherapy; MEK inhibitor; Cisplatin; Internal medicine; Toxicity; Oncology; Urology; Gastroenterology; Surgery; Cancer; MAPK/ERK pathway; Biology; Kinase; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003197097,0.0001291995,0.0006662752,0.0001482066,0.00009571487,0.000007815244,0.00006667955,0.00002188895,0.00005707633],"category_scores_gemma":[0.00002788358,0.0001110694,0.0000564937,0.0002502076,0.00006355385,0.0001935868,0.00002101313,0.000196177,3.086257e-9],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000118522,"about_ca_system_score_gemma":0.0001934915,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006685581,"about_ca_topic_score_gemma":0.001805213,"domain_scores_codex":[0.9986109,0.00006874357,0.0005307379,0.0001750057,0.0004697968,0.0001448479],"domain_scores_gemma":[0.9987301,0.00005767057,0.0005612245,0.00008146022,0.0004995988,0.00006990205],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08164002,0.009250029,0.6391133,0.0001753119,0.0004457714,0.00005437454,0.004343249,0.0001991462,0.0008209906,6.06087e-7,0.0002425218,0.2637146],"study_design_scores_gemma":[0.3152056,0.03354642,0.6469772,0.000482987,0.0003339007,0.00006521514,0.002213727,0.00005707235,0.0006331716,0.000006243028,0.0003411282,0.0001373902],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929435,0.005212801,0.00001348052,0.0001694612,0.0001096007,0.001408011,0.0001296668,0.000003670858,0.000009786952],"genre_scores_gemma":[0.9986628,0.0005821191,0.0003304817,0.00008276037,0.00005884228,0.0002175775,0.00001187417,0.00002743065,0.0000261402],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2635773,"threshold_uncertainty_score":0.4529278,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01100035852035191,"score_gpt":0.2962305676332977,"score_spread":0.2852302091129458,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}